When metformin is used alone as monotherapy, it lowers A1C by about 1% to 2% on average. A1C is a measure of longer-term blood sugar control. In most patients, metformin is suggested as the initial treatment for type 2 diabetes, but its glucose-lowering effect may not be adequate for all patients if used alone.